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Diacylglycerols which activate protein kinase C have the 1,2-sn configuration. Short-chain saturated fatty 
acids or long-chain unsaturated fatty acids are required for supporting the potency of these lipids. Using 
alkyl analogs such as l-O-decyl-2-O-decanoylglycerol, 1-O-deeanoyl-2-O-decylglycerol, 1,2-O-didecyl- 
glycerol, 1-O-hexadecyl-2-O-acetylglycerol and 1-O-decyl-2-O-acetylglycerol, we showed that the ether 
bond was consistently associated with a loss of activity to varying extents. The results suggest that the ester 
bond in the 1-position is a major determinant of diacylglycerol-mediated protein kinase activation. 
Protein kinase C; Diacylglycerol; Alkyl analog 
1. INTRODUCTION 
Extracellular ligands produce signals from the 
surface which are transduced into the cell through 
various strategies. Signaling of a large class of 
ligands, including hormones, neurotransmitters 
and mitogens, appears to be mediated through 
Ca 2+ mobilization and protein kinase C activation 
[1,2]. Upon interaction with specific receptors, the 
ligand enhances the polyphosphoinositide turnover 
which results in the transient accumulation of 
diacylglycerol and inositol 1,4,5-trisphosphate. 
The neutral lipid is the physiological activator of 
the protein kinase C, while inositol 1,4,5-trisphos- 
phate mobilizes Ca 2÷ from its internal stores. As a
consequence, this class of ligands control both 
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Ca2+-dependent processes and protein kinase C- 
catalyzed protein phosphorylation (reviews [3-5]). 
Tumor-promoting phorbol esters substitute for 
diacylglycerol in activating protein kinase C [6]. 
However, the involvement of this enzyme in tumor 
promotion remains to be assessed. 
Some specific structural requirements of diacyl- 
glycerol as well as phorbol esters for protein kinase 
C activation have been shown in early reports 
[6,7]. Thereafter, in biochemical and theoretical 
studies, we have shown that the hydroxyl group in 
the 3-position of diacylglycerol was required for 
activity, and we have emphasized the importance 
of its orientation into the lipid bilayer [8,9]. In ad- 
dition, protein kinase C activation has been de- 
scribed as stereospecific [10,11] and therefore 
1,2-sn appeared to be the active configuration of 
diacylglycerol. Moreover, it has been reported that 
esterification with saturated short-chain fatty acid 
or unsaturated long-chain fatty acid led to greater 
efficiency of these compounds [8,12,13]. 
We have carried out further experiments in 
order to evaluate the importance of ester bonds in 
the activation process of protein kinase C, both in 
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vitro and in intact cells. We report here that the in- 
troduction of an ether bond in the l-position 
caused a dramatic loss of activity whereas, at 
variance, an ether bond in the 2-position yielded a 
compound which was still active, though markedly 
less so than the diacylglycerol counterpart. 
2. MATERIALS AND METHODS 
2.1. Materials and chemicals 
Rabbit platelets were washed according to Baen- 
ziger and Majerus [14]. Protein kinase C was par- 
tially purified from mouse brain as described [15]. 
[T-32p]ATP was obtained from New England 
Nuclear (USA) and carrier-free np from Amer- 
sham (England). TPA was purchased from CCR 
(USA). R 59022 was kindly provided by Dr de 
Chaffoy de Courcelles (Janssen Pharmaceutica 
Research Laboratories); 1-O-octadecyl-2-acetyl- 
sn-glycerol was provided by Novabiochem and 
other chemicals including 1,2-rac-didecanoyl- 
glycerol were obtained from Sigma (USA). 
2.2. Synthetic procedure 
As racemic mixtures, the following compounds 
w.ere synthesized: 
hydride (60°C, 30 min) followed by treatment with 
decylmethanesulfonate (80°C, 2 H) in DMF led to 
the triether 4 (yield 64070) which was hydrogenolys- 
ed in the same manner as 3 to obtain 1-O-2-O- 
didecylglycerol, IV (yield 76070). Preparation of 
1-O-decanoyl-2-O-decylglycerol, (III) was per- 
formed according the same procedure as for IV 
starting from 1-O-decanoylglycerol. The whole 
procedure is summarized below. 
CH,~OR (C6HO~CCI CHzOR 
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Alkylacyl and dialkylglycerols were prepared 
mainly as in [16,17], including several modifica- 
tions, l-O-Decylglycerol (1) prepared according to 
Baumann et al. [18] was converted into its trityl 
derivative, 2 (yield 75070), and esterified in 3 by 
classical action of decanoyl chloride in benzene/ 
pyridine (yield 91070). Catalytic hydrogenolysis 
(10070 Pd/C) of 3 led to a mixture of the two posi- 
tional isomers I and II due to spontaneous acyl 
migration (yield 85070). Separation of I and II was 
performed by chromatography on a silica gel col- 
umn using 15070 ether in petroleum ether as eluent. 
Etherification of 2 by prior treatment with sodium 
All structures were confirmed by IR (Pye- 
Unicam SPr200) and ~H NMR (Varian EM 360 or 
Briicker 250 MHz) in CDC13 with TMS as an inter- 
nal standard. Elemental analyses were consistent 
with the proposed structures. The physicochemical 
properties and spectral data of the final com- 
pounds are summarized in table 1. 
In addition, l-O-octadecyl-2-O-acetyl-rac-gly- 
cerol was synthesized using the procedure de- 
scribed above. 
2.3. Assay for protein kinase C in cell-free system 
Protein kinase C was assayed asin [2]. The reac- 
tion mixture (125/zl) contained 2.5/zmol Tris-HCl 
buffer at pH 7.5, 10/zg phosphatidylserine or brain 
extract ype III from Sigma, 0.5/zmol magnesium 
acetate, 2.5 nmol [~,-nP]ATP (approx. 3× 105 
dpm), 15/~g histone H~ and 0.4-0.5/zg enzyme 
preparation. Diacylglycerol and analogs, CaCl2 
and EGTA were added as indicated in the text. 
Neutral ipids and phospholipids were dissolved in 
chloroform, then dried under an N2 stream and 
resuspended in the incubation buffer by sonication 
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Table l 
Physicochemical constants of alkylacylglycerols I and II, acylglycerol III and dialkylglycerol IV 
Compound Formula IRa(KBr)p(cm -l) 1H NMR a(MHz) (ppm) 
I b CH20(CH2)gCH3 3460 (O-H), 1740 (C=O), 250 MHz: 4.99 (quintet, IH, CHOCO), 
I 1170, 1120 (C-O-C) 3.83 (m,2H, CH2OH), 3.64 (m,2H, C 2OR), 
CHOCO (CH2)sCH3 3.47 (m,2H, OCH2), 2.37 (t,2H, OCOCH2) 
I 
CH2OH 
Iib 
III b 
IV b 
CH20(CH2)gCH3 
f 
CHOH 
I 
CH2OCO(CH2)sCH3 
CH20(CH2)9CH3 
f 
CHO(CH2)9CH3 
I 
CH2OH 
3400 (O-H), 1740 (C= O), 
1175, 1125 (C-O-C) 
3460 (O-H), 1130 (C-O-C) 
CH2OCO(CH2)sCH3 3450 (O-H), 1740 (C= O), 
[ 1090 (C-O) 
CHO(CH2)9CH3 
CH2OH 
250 MHz:4.14 (m,2H, CH2OCOi, 3.46 
(m,3H, 2CH20+ CHO), 2.35 (t,2H, OCOCH2) 
80 MHz: 3.57 (m,9H, 4CH20 + CHO) 
250 MHz:4.15 (m,2H, CH2OCO), 3.51 
(m,5H, 2CH20 + CHO), 2.32 
(quadruplet, 2H, OCOCH2) 
a Key peaks 
b Viscous oil at room temperature 
as described [19]. Incubation was carried out for 3 
min at 30°C. The reaction was stopped by transfer- 
ring 50/~1 aliquots onto squares of Whatman paper 
ET31 followed by several 25070 trichloroacetic a id 
baths. The radioactivity was determined by 
Cerenkov radiations. 
2.4. Protein kinase C assay in intact platelets 
Washed cells (4 x 109) were labeled with 0.5 mCi 
32pi n I ml phosphate-free Tyrode's olution con- 
taining 1 mM EGTA, 0.25°70 BSA and 10 mM Tris- 
HC1 buffer (pH 7.4), at room temperature. The 
platelets were then spun down and resuspended in 
the same buffer (50/zl) containing 1.5 mM CaCI2 
instead of 1 mM EGTA. Stimulation with throm- 
bin, diacylglycerol and analogs was as indicated in 
the figure legends. Neutral lipids were added as 
sonicates in the incubation buffer. Labeled pro- 
teins were analyzed by SDS-polyacrylamide g l 
electrophoresis and autoradiography. Therelative 
intensity of the 43 kDa protein was quantified by 
densitometric tracing of the autoradiogram using a 
Joyce and Loebl chromatogram scanner. 
3. RESULTS AND DISCUSSION 
1,2-O-Dioleoylglycerol and 1,2-O-didecanoyl- 
glycerol (diC~0) are currently used as exogenous ac- 
tivators. Although the two compounds exhibit a 
similar potency in the in vitro assay, the latter 
more easily permeates intact cells. With the pur- 
pose of examining the importance of the ester 
bond, we prepared analogs of diC10 containing one 
or two ether bonds. In addition, we tested the ac- 
tivity of two precursors of the platelet-activating 
factor: 1-O-hexadecyl-2-O-acetylglycerol (AAG- 
16) and 1-O-octadecyl-2-O-acetylglycerol (AAG- 
18). 
In vitro tests using mouse brain enzyme have 
shown that the monoether in the 2-position (III), 
though stimulating the enzyme at concentrations 
higher than diClo, elicited a marked activating ef- 
37 
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fect. In contrast, monoether in the 1-position (I) 
and diether IV were poorly active in this assay. 
Likewise, 1-alkyl-3-acylglycerol II was revealed as 
being devoid of activity (fig. 1). It should be noted 
that the experiments were performed in the pre- 
sence of either 10/zM CaCI2 or 0.5 mM EGTA and 
that results were essentially similar. 
Further tests were conducted in intact platelets. 
One of the major substrates of protein kinase C in 
platelets is a protein of 43 kDa. The degree of 
phosphorylation of this substrate was used as an 
index of the enzyme activity in these cells. Assum- 
ing that alkyl analogs are as permeable as the 
diacylglycerol parent, the replacement of ester 
bonds by ether bonds leads to a marked loss of ac- 
tivity which affects, like in the in vitro assay, 
preferentially the monoether in the 1-position, and 
the diether. The activity of the latter is approx- 
imately one-tenth that of diC1o, as shown in fig.2. 
'o lO 
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• • 
0 
0 1 lO 
I 
lO0 
DIACYLGLYCEROL AND ANALOGS (&Jg/ml) 
Fig. 1. Dose dependence of protein kinase C activation in 
response to diC~o (e) and analogs: l-O-decyl-2-O- 
decanoyl-rac-glycerol (v); l-O-decanoyl-2-O-decyl-rac- 
glycerol (o) 1,2-O-didecyl-rac-glycerol (v) and 1-O- 
decyl-3-O-decanoyl-rac-glycerol (m). The assay was 
performed as described in section 2; 0.5 mM EGTA was 
added. The experiment shown is representative of 3 
superimposable experiments. 
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Fig.2. Effect of diacylglycerol diCto and diether analog 
on phosphorylation of 43 kDa protein. Cells were 
incubated at 37°C in Tyrode's olution (lane a) or 1,2-O- 
didecyl-rac-glycerol at20/zg/ml (lane b) and 100/zg/ml 
(lane c) or 1,2-O-didecyl-rac-glycerol at 2/zg/ml (lane 3), 
20/zg/ml (lane f) and 100/zg/ml (lane g). The molecular 
mass markers were run in lane d. 
As a result of time course experiments using the 
monoether in C-2 (III), we were able to show that 
replacement of the 2-ester did not affect the half- 
life of the phosphorylated state of the protein 43 
kDa which was close to 30 min (fig.3). The addi- 
Fig.3. Autoradiogram of SDS-polyacrylamide gel 
electrophoresis of platelet proteins. Cells were washed 
and 32p labeled as described in section 2, then incubated 
at 37°C in Tyrode's olution (lanes a) containing either 
100/~g/ml of l-O-decyl-2-O-decanoyl-rac-glycerol (lanes 
b), 100/zg/ml of 1-O-decyl-2-O-decanoyl-rac-glycerol + 
0.1 mM R 59022 (lanes c) or 100#g/ml of diC~0 (lanes 
d) for l min, 15 rain, 30 min and I h (from left to right 
lanes) except for diC~o treatment, which was for only 1, 
15 and 30 min. 
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43kDa 
Fig.4. Autoradiogram of SDS-polyacrylamide gel 
electrophoresis: Time course of 1-O-hexadecyl-2-O- 
acetylglycerol-induced phosphorylation of 43 kDa 
protein in platelets. Cells were stimulated at 37°C with 
either 50 ng/ml TPA for 1 min (lane a) and 2 min (lane 
b) with 2 units/ml thrombin for 30 s (lane c) and 1 min 
(lane d) or with 120/~g/ml 1-O-hexadecyl-2-O-acetyl- 
glycerol for 30 s (lane ), 1 min (lane f) and 2 min (lane 
g). Unstimulated controls (lane h). 
promyelocytic cells HL60 to macrophage-like c lls 
[22]. Our results uggest that the biological activity 
of this compound may actually result from protein 
kinase C activation. 
In summary, the substitution of the ether for the 
ester bond in the diacylglycerol molecule leads to 
a loss of activity which is more drastic when the 
alkyl group is in the 1-position. These results are in 
agreement with recent studies conducted in a 
mixed micelle assay by Ganong et al. [23], which 
have shown that an amide linkage in C-2, and not 
in C-I, yields an active analog of diacylglycerol. It 
is of interest o note that the ether in C-2 has the 
potential for being a good tool in investigating the 
physiological role of protein kinase C. 
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tion of R 59022, an inhibitor of diacylglycerol 
kinase [20], no longer sustained the phosphoryl- 
ated state. The rapid drop in degree of phosphoryl- 
ation suggests that diacylglycerol (and analogs)- 
induced platelet activation may be associated with 
a concomitant increase in protein phosphatase ac- 
tivity. Alternatively, dephosphorylation may ac- 
count for a possible activator-induced 'down 
regulation' of protein kinase C in these cells [21]. 
Conversely, the 43 kDa protein may have become 
more intensively phosphorylated as a function of 
time in control samples, presumably due to slowly 
occurring spontaneous platelet activation. 
Furthermore, we investigated the effects of 1-O- 
hexadecyl-2-O-acetylglycerol (AAG-16) from com- 
mercial sources and 1-O-octadecyl-2-O-acetyl- 
glycerol (AAG-18) synthesized in the laboratory. 
These two precursors of the platelet-activating fac- 
tor are poorly active in the in vitro assay (not 
shown). However, AAG-16 exhibited a small but 
detectable activity in platelets whereas AAG-18 
was totally inactive. The effects of usual ac- 
tivators, thrombin and TPA, on protein phos- 
phorylation were compared with those of AAG- 16, 
as shown in fig.4. It has been reported that 
AAG-16 induces, like TPA, the differentiation of 
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